A 2019 review published in Cell Tissue Research (Gwyer D et al.) examined preclinical evidence for BPC-157's effects on musculoskeletal tissue, noting the peptide's potential to support muscle, tendon, and ligament repair pathways in animal models
Researchers note that intranasal delivery may especially increase the bioavailability of peptide therapeutics and present an appealing alternative to injection [14, 15, 16]
Lyophilized peptides are stored at -20C protected from light and moisture, with a stability of 24 months or more
GLOW Blend is commonly administered by subcutaneous injection
Diabetes 2021 + Zhang Q, et al
These platforms can protect peptides from degradation, target them to specific tissues or immune cell populations, and provide sustained release over extended periods